First Squawk(@FirstSquawk):GENMAB AND ABBVIE SAY EPCORITAMAB IN COMBINATION WITH R-CHOP DEMONSTRATED A STATISTICALLY SIGNIFICANT IMPROVEMENT IN PROGRESSION-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), WITH THE PHASE 3 TRIAL SHOWING A 51% REDUCTION IN THE RISK OF PROGRESSION OR DEATH

First Squawk

@FirstSquawk

Firstsquawk Is a Global Financial (News) Squawk Service Specialising In Financial Markets, Macro, Geopolitics,politics

Joined July 2015

252 Following 578.1K Followers

First Squawk@FirstSquawk

2026.10.05 18:55

GENMAB AND ABBVIE SAY EPCORITAMAB IN COMBINATION WITH R-CHOP DEMONSTRATED A STATISTICALLY SIGNIFICANT IMPROVEMENT IN PROGRESSION-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), WITH THE PHASE 3 TRIAL SHOWING A 51% REDUCTION IN THE RISK OF PROGRESSION OR DEATH